Human Molecular Genetics Advance Access originally published online on July 6, 2006
Human Molecular Genetics 2006 15(16):2490-2508; doi:10.1093/hmg/ddl171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers
1 Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA, 2 Department of Biochemical Engineering, State University of New York at Stony Brook, NY 11794, USA, 3 St Jude Children’s Research Hospital, Memphis, TN 38105, USA and 4 Department of Endocrinology, St Bartholomew’s Hospital, Queen Mary University of London, London EC1M 6BQ, UK
* To whom correspondence should be addressed. Tel: +1 5163678417; Fax: +1 5163678453; Email: krainer{at}cshl.edu
Received May 16, 2006; Accepted July 4, 2006
Numerous disease-associated point mutations exert their effects by disrupting the activity of exonic splicing enhancers (ESEs). We previously derived position weight matrices to predict putative ESEs specific for four human SR proteins. The score matrices are part of ESEfinder, an online resource to identify ESEs in query sequences. We have now carried out a refined functional SELEX screen for motifs that can act as ESEs in response to the human SR protein SF2/ASF. The test BRCA1 exon under selection was internal, rather than the 3'-terminal IGHM exon used in our earlier studies. A naturally occurring heptameric ESE in BRCA1 exon 18 was replaced with two libraries of random sequences, one seven nucleotides in length, the other 14. Following three rounds of selection for in vitro splicing via internal exon inclusion, new consensus motifs and score matrices were derived. Many winner sequences were demonstrated to be functional ESEs in S100-extract-complementation assays with recombinant SF2/ASF. Motif-score threshold values were derived from both experimental and statistical analyses. Motif scores were shown to correlate with levels of exon inclusion, both in vitro and in vivo. Our results confirm and extend our earlier data, as many of the same motifs are recognized as ESEs by both the original and our new score matrix, despite the different context used for selection. Finally, we have derived an increased specificity score matrix that incorporates information from both of our SF2/ASF-specific matrices and that accurately predicts the exon-skipping phenotypes of deleterious point mutations.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F.-O. Desmet, D. Hamroun, M. Lalande, G. Collod-Beroud, M. Claustres, and C. Beroud Human Splicing Finder: an online bioinformatics tool to predict splicing signals Nucleic Acids Res., May 1, 2009; 37(9): e67 - e67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Piva, M. Giulietti, L. Nocchi, and G. Principato SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans Bioinformatics, May 1, 2009; 25(9): 1211 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wang and F. Cambi Heterogeneous Nuclear Ribonucleoproteins H and F Regulate the Proteolipid Protein/DM20 Ratio by Recruiting U1 Small Nuclear Ribonucleoprotein through a Complex Array of G Runs J. Biol. Chem., April 24, 2009; 284(17): 11194 - 11204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Sanford, X. Wang, M. Mort, N. VanDuyn, D. N. Cooper, S. D. Mooney, H. J. Edenberg, and Y. Liu Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts Genome Res., March 1, 2009; 19(3): 381 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sen, I. Talukdar, and N. J. G. Webster SRp20 and CUG-BP1 Modulate Insulin Receptor Exon 11 Alternative Splicing Mol. Cell. Biol., February 1, 2009; 29(3): 871 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Friedman, M. B. Stadler, N. Shomron, Y. Ding, and C. B. Burge Ab initio identification of functionally interacting pairs of cis-regulatory elements Genome Res., October 1, 2008; 18(10): 1643 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Mauger, C. Lin, and M. A. Garcia-Blanco hnRNP H and hnRNP F Complex with Fox2 To Silence Fibroblast Growth Factor Receptor 2 Exon IIIc Mol. Cell. Biol., September 1, 2008; 28(17): 5403 - 5419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Churchill, J. G. Carter, C. Ramsden, S. J. Turner, A. Yeung, P. E. C. Brenchley, and D. W. Ray VEGF Polymorphisms Are Associated with Severity of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3611 - 3616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Goina, N. Skoko, and F. Pagani Binding of DAZAP1 and hnRNPA1/A2 to an Exonic Splicing Silencer in a Natural BRCA1 Exon 18 Mutant Mol. Cell. Biol., June 1, 2008; 28(11): 3850 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zhang, W.-H. Li, A. R. Krainer, and M. Q. Zhang RNA landscape of evolution for optimal exon and intron discrimination PNAS, April 15, 2008; 105(15): 5797 - 5802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Mayshar, E. Rom, I. Chumakov, A. Kronman, A. Yayon, and N. Benvenisty Fibroblast Growth Factor 4 and Its Novel Splice Isoform Have Opposing Effects on the Maintenance of Human Embryonic Stem Cell Self-Renewal Stem Cells, March 1, 2008; 26(3): 767 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Davidson, H. Northrup, T. M. King, J. M. Fletcher, I. Townsend, G. H. Tyerman, and Kit Sing Au Genes in Glucose Metabolism and Association With Spina Bifida Reproductive Sciences, January 1, 2008; 15(1): 51 - 58. [Abstract] [PDF]
|
|
|
|
|
|
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aartsma-Rus and G.-J. B. van Ommen Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications RNA, October 1, 2007; 13(10): 1609 - 1624. [Abstract] [Full Text] [PDF]
|
|